Announcement of The Consolidated Financial Report for The 2nd Quarter of 2021
2021.8.5
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2021/08/05 | Time of announcement | 14:35:43 |
| Subject | Announcement of The Consolidated Financial Report for The 2nd Quarter of 2021 | ||||
| Date of events | 2021/08/05 | To which item it meets | paragraph 31 | ||
| Statement | 1.Date of the financial reports submitted to the board of directors or approved by the board of directors:2021/08/05 2.Date of the financial reports approved by the audit committee:2021/08/05 3.Start and end dates of financial reports of the reporting period:2021/01/01~2021/06/30 4.Operating revenue accumulated from 1/1 to end of the period (thousand NTD):2,007,230 5.Gross profit (loss) from operations accumulated from 1/1 to end of the period (thousand NTD):1,257,184 6.Net operating income (loss) accumulated from 1/1 to end of the period (thousand NTD):491,217 7.Profit (loss) before tax accumulated from 1/1 to end of the period (thousand NTD):347,658 8.Profit (loss) accumulated from 1/1 to end of the period (thousand NTD):230,880 9.Profit (loss) during the period attributable to owners of parent accumulated from 1/1 to end of the period (thousand NTD):235,023 10.Basic earnings (loss) per share accumulated from 1/1 to end of the period (NTD):0.95 11.Total assets end of the period (thousand NTD):9,523,735 12.Total liabilities end of the period (thousand NTD):3,288,927 13.Equity attributable to owners of parent end of the period (thousand NTD):5,616,437 14.Any other matters that need to be specified:None |
||||